James D McCully1, Anthony J Rousou, Robert A Parker, Sidney Levitsky. 1. Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA. james_mccully@hms.harvard.edu
Abstract
BACKGROUND: We have recently shown that the cardioprotection afforded by cardioplegia is affected by age and gender and is less effective in the aged female rabbit heart compared with the aged male rabbit heart. We hypothesized that these differences were due to age and gender-specific modulation of mitochondrial oxygen consumption and mitochondrial free matrix calcium ([Ca2+](Mito)) content occurring during early reperfusion. METHODS: To test this hypothesis, 104 male and female rabbit hearts, mature (15 to 20 weeks) and aged (>32 months), were subjected to Langendorff perfusion. Control hearts were perfused for 75 minutes. Global ischemia hearts were underwent 30 minutes of equilibrium, 30 minutes of global ischemia, and 15 minutes of reperfusion. Cardioplegia (potassium/magnesium) +/- diazoxide was infused 5 minutes before global ischemia. Mitochondria were isolated from left ventricular tissue and used for the measurement of oxygen consumption and [Ca2+](Mito). RESULTS: Mitochondrial oxygen consumption was significantly increased in the mature and aged female hearts in all treatment groups (p < 0.001 versus male). Cardioplegia +/- diazoxide modulated mitochondrial oxygen consumption, but these effects were significantly decreased in the aged heart and in the female heart (p < 0.001 each versus male). Cardioplegia (potassium/magnesium) significantly decreased [Ca2+](Mito) (p < 0.001 versus global ischemia) in aged but not mature hearts. The addition of diazoxide to potassium/magnesium significantly decreased [Ca2+](Mito) in mature and aged males (p < 0.001 versus potassium/magnesium) but not in females. CONCLUSIONS: These results demonstrate that mitochondrial oxygen consumption and [Ca2+](Mito) are modulated by age and gender and play an important role in the differences observed between mature and aged male and female response to global ischemia and the cardioprotection afforded by cardioplegia +/- diazoxide.
BACKGROUND: We have recently shown that the cardioprotection afforded by cardioplegia is affected by age and gender and is less effective in the aged female rabbit heart compared with the aged male rabbit heart. We hypothesized that these differences were due to age and gender-specific modulation of mitochondrial oxygen consumption and mitochondrial free matrix calcium ([Ca2+](Mito)) content occurring during early reperfusion. METHODS: To test this hypothesis, 104 male and female rabbit hearts, mature (15 to 20 weeks) and aged (>32 months), were subjected to Langendorff perfusion. Control hearts were perfused for 75 minutes. Global ischemia hearts were underwent 30 minutes of equilibrium, 30 minutes of global ischemia, and 15 minutes of reperfusion. Cardioplegia (potassium/magnesium) +/- diazoxide was infused 5 minutes before global ischemia. Mitochondria were isolated from left ventricular tissue and used for the measurement of oxygen consumption and [Ca2+](Mito). RESULTS: Mitochondrial oxygen consumption was significantly increased in the mature and aged female hearts in all treatment groups (p < 0.001 versus male). Cardioplegia +/- diazoxide modulated mitochondrial oxygen consumption, but these effects were significantly decreased in the aged heart and in the female heart (p < 0.001 each versus male). Cardioplegia (potassium/magnesium) significantly decreased [Ca2+](Mito) (p < 0.001 versus global ischemia) in aged but not mature hearts. The addition of diazoxide to potassium/magnesium significantly decreased [Ca2+](Mito) in mature and aged males (p < 0.001 versus potassium/magnesium) but not in females. CONCLUSIONS: These results demonstrate that mitochondrial oxygen consumption and [Ca2+](Mito) are modulated by age and gender and play an important role in the differences observed between mature and aged male and female response to global ischemia and the cardioprotection afforded by cardioplegia +/- diazoxide.
Authors: D Abramov; M G Tamariz; J Y Sever; G T Christakis; G Bhatnagar; A L Heenan; B S Goldman; S E Fremes Journal: Ann Thorac Surg Date: 2000-09 Impact factor: 4.330
Authors: Michael C Riddell; Sara L Partington; Nicole Stupka; David Armstrong; Courtney Rennie; Mark A Tarnopolsky Journal: Int J Sport Nutr Exerc Metab Date: 2003-12 Impact factor: 4.599
Authors: Kamila Moskowitzova; Borami Shin; Kaifeng Liu; Giovanna Ramirez-Barbieri; Alvise Guariento; David Blitzer; Jerusha K Thedsanamoorthy; Rouan Yao; Erin R Snay; James A H Inkster; Arzoo Orfany; David Zurakowski; Douglas B Cowan; Alan B Packard; Gary A Visner; Pedro J Del Nido; James D McCully Journal: J Heart Lung Transplant Date: 2018-09-28 Impact factor: 10.247
Authors: Kendra M Black; Reanne J Barnett; Monoj K Bhasin; Christian Daly; Simon T Dillon; Towia A Libermann; Sidney Levitsky; James D McCully Journal: Physiol Genomics Date: 2012-09-11 Impact factor: 3.107
Authors: Ingeborg Friehs; Douglas B Cowan; Yeong-Hoon Choi; Kendra M Black; Reanne Barnett; Manoj K Bhasin; Christian Daly; Simon J Dillon; Towia A Libermann; Francis X McGowan; Pedro J del Nido; Sidney Levitsky; James D McCully Journal: Am J Physiol Heart Circ Physiol Date: 2012-12-21 Impact factor: 4.733
Authors: Emily Honzel; Samantha Nemeth; Brigitte E Kazzi; Alexander P Kossar; Jocelyn Sun; Yuji Kaku; Koji Takeda; Hiroo Takayama; Michael Argenziano; Jessica Spellman; Andrea Miltiades; Kenmond Fung; James Beck; Craig R Smith; Paul Kurlansky; Isaac George Journal: Eur J Cardiothorac Surg Date: 2022-10-04 Impact factor: 4.534
Authors: Akihiro Masuzawa; Kendra M Black; Christina A Pacak; Maria Ericsson; Reanne J Barnett; Ciara Drumm; Pankaj Seth; Donald B Bloch; Sidney Levitsky; Douglas B Cowan; James D McCully Journal: Am J Physiol Heart Circ Physiol Date: 2013-01-25 Impact factor: 4.733
Authors: James D McCully; Douglas B Cowan; Christina A Pacak; Ioannis K Toumpoulis; Haripriya Dayalan; Sidney Levitsky Journal: Am J Physiol Heart Circ Physiol Date: 2008-10-31 Impact factor: 4.733